Search

Your search keyword '"Van Wijngaerden, Eric"' showing total 440 results

Search Constraints

Start Over You searched for: Author "Van Wijngaerden, Eric" Remove constraint Author: "Van Wijngaerden, Eric"
440 results on '"Van Wijngaerden, Eric"'

Search Results

2. Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study

3. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

4. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

5. Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort

6. A public health value-based healthcare paradigm for HIV

9. Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial

11. Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey

12. Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length Genomes

14. Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

15. The genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary rates.

16. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation

18. Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study

19. A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue

20. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

22. Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study

25. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

27. Modulation of thromboinflammation in hospitalized COVID‐19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn‐Antico study

29. A public health value-based healthcare paradigm for HIV.

34. Lessons in Developing a Full-Genome Next-Generation Sequencing Pipeline for Molecular Epidemiology of Hcv

37. Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies

38. Corrigendum to “itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens”

40. sj-pdf-1-avt-10.1177_13596535211062388 ��� Supplemental Material for Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1-infected patients: 336-week rollover study of phase 2b and 3 clinical studies

41. Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies

43. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from AASERT study

44. Successful double-lung transplantation from a donor previously infected with SARS-CoV-2

45. Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards

46. Invasive aspergillosis in the intensive care unit

47. Autoantibodies against granulocyte macrophage colony-stimulating factor and Nocardia infection in solid organ transplant recipients.

48. Autoantibodies against granulocyte macrophage colony-stimulating factor and Nocardia infection in solid organ transplant recipients

50. Immunogenicity and Safety of the 9-Valent Human Papillomavirus Vaccine in Solid Organ Transplant Recipients and Adults Infected With Human Immunodeficiency Virus (HIV)

Catalog

Books, media, physical & digital resources